Kiraz, Yağmur
Kiraz, Y.
****************************************************************************************************************************************
Dr. Yağmur Kiraz was graduated from İstanbul University, Department of Molecular Biology and Genetics in 2013. She earned her MSc and PhD from İzmir Institute of Technology, Department of Molecular Biology and Genetics. During her PhD studies, she received a scholarship from TUBITAK-BIDEB-2214A International Fellowship Programme for PhD students and worked in Health Science Center, Stony Brook University, NY, USA between 2017 and 2019 to conduct her PhD project. Her PhD project focused on “Targeting Sphingolipids to Overcome Imatinib Resistance in Ph+ Acute Lymphoblastic Leukemia”. Her research is placed around drug resistance mechanisms in different type of leukemia and the involvement of sphingolipids in chemotherapy resistance. During her graduate education, she received many prestigious awards from different institutions/conferences including “Health Security Partners Futures Fellowship”; “Qualified in a global competition among young scientists worldwide to participate in the 65th Lindau Nobel Laureate Meeting”; “Youth Travel Fund” from 2019 FEBS Special Meeting; “Young Researcher Award” from Turkish Hematology Association. Dr. Kiraz has more than 30 abstracts presented in national and international conferences and over 15 articles published in international journals/books.
Date issued
Type
Fulltext
Results 1-5 of 5 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | |
---|---|---|---|
1 | 2023 | Exploring PI3K Pathway Inhibitors for Acute Myeloid Leukemia: A Drug-Repurposing Approach | Ergun, C.; Kiremitci, B.Z.; Arslantas, G.; Bozkurt, B.; Ayna Duran, Gizem ; Kiraz Durmaz, Yağmur |
2 | 2024 | Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening | Özay, Başak; Tükel, Ezgi Yağmur; Ayna Duran, Gizem ; Kiraz, Yağmur |
3 | 2023 | In Silico Approach for Identification of PI3K/mTOR Dual Inhibitors for Multiple Myeloma Treatment | Masalacı, İlke; Akdoğan, Yaren; Mutlu Özge; Eyvaz, Hande; Kıraz, Yağmur |
4 | 2024 | In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment | Tukel, Ezgi Yağmur; Ateş, Onur; Kiraz, Yağmur |
5 | 2024 | Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities | Budak, Betül; Tükel, Ezgi Yağmur; Turanlı, Beste; Kiraz, Yağmur |
Claim Researcher Page
Check the encrypted string of this email, put the correct string in the box below and click "Go" to validate the email and claim this profile.
Emails: y a g m * * * * * * * * @ * * * * * * u . t r